HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Dawn Phillips Selected Research

Dawn Phillips Research Topics

Disease

6Hypophosphatasia
06/2019 - 01/2016
2Macular Degeneration (Age-Related Maculopathy)
01/2022 - 01/2020
2alpha-Mannosidosis
06/2020 - 11/2018
2Pain (Aches)
06/2019 - 01/2016
2Rare Diseases (Rare Disease)
01/2018 - 01/2016
2Rickets (Rachitis)
01/2016 - 01/2016
2Muscle Weakness
01/2016 - 01/2016
2Glycogen Storage Disease Type II (Pompe's Disease)
04/2015 - 06/2013
1Atrophy
01/2022
1Mucopolysaccharidosis VI (Syndrome, Maroteaux-Lamy)
01/2021
1Mucopolysaccharidoses
01/2021
1Neurologic Manifestations (Neurological Manifestations)
06/2020
1Chronic Hepatitis (Chronic Active Hepatitis)
01/2019
1Craniosynostoses (Craniosynostosis)
01/2019
1Infantile Hypophosphatasia
01/2019
1Deafness (Deaf Mutism)
01/2019
1Congenital Abnormalities (Deformity)
01/2016
1Bone Fractures (Bone Fracture)
01/2016
1Osteomalacia
01/2016
1Cardiomegaly (Heart Hypertrophy)
06/2013
1Neuromuscular Diseases (Neuromuscular Disease)
06/2013
1Respiratory Insufficiency (Respiratory Failure)
06/2013
1Breast Neoplasms (Breast Cancer)
11/2003
1Neoplasms (Cancer)
11/2003
1Wounds and Injuries (Trauma)
02/2002

Drug/Important Bio-Agent (IBA)

5N- (4'- fluorobutyrophenone)- 4- (4- chlorophenyl)pyridinium (HPP(+))IBA
06/2019 - 01/2016
3asfotase alfaIBA
01/2019 - 01/2016
2Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
01/2022 - 01/2020
2alpha-Mannosidase (LAMAN)IBA
06/2020 - 11/2018
1Retinaldehyde (Retinal)IBA
01/2022
1galsulfaseFDA Link
01/2021
1Ranibizumab (Lucentis)FDA Link
01/2020
1Bevacizumab (Avastin)FDA Link
01/2020
1Coenzyme A (CoA)IBA
01/2018
1poly(n-octyl methacrylate)IBA
01/2018
1IsoenzymesIBA
01/2016
1Alkaline PhosphataseIBA
01/2016
1human GAA protein (Myozyme)FDA Link
04/2015
1GlycogenIBA
06/2013
1alpha-Glucosidases (Acid Maltase)IBA
06/2013
1AcidsIBA
06/2013
1Methionine (L-Methionine)FDA Link
11/2003
1Estrogen ReceptorsIBA
11/2003
1Estrogen Receptor alphaIBA
11/2003
1Anti-Bacterial Agents (Antibiotics)IBA
02/2002

Therapy/Procedure

5Enzyme Replacement Therapy
01/2021 - 06/2013
2Therapeutics
01/2018 - 01/2016
1Enzyme Therapy
06/2020
1Activities of Daily Living (ADL)
06/2019
1Physical Therapy Modalities (Physical Therapy Technique)
01/2016
1Artificial Respiration (Mechanical Ventilation)
06/2013
1Debridement
02/2002
1Free Tissue Flaps
02/2002